YU45724B - Postupak za dobijanje kristalnog kalcijum pseudomonata ili njegovog hidrata - Google Patents

Postupak za dobijanje kristalnog kalcijum pseudomonata ili njegovog hidrata

Info

Publication number
YU45724B
YU45724B YU101385A YU101385A YU45724B YU 45724 B YU45724 B YU 45724B YU 101385 A YU101385 A YU 101385A YU 101385 A YU101385 A YU 101385A YU 45724 B YU45724 B YU 45724B
Authority
YU
Yugoslavia
Prior art keywords
hydrate
calcium pseudomonate
obtaining crystal
crystal calcium
pseudomonate
Prior art date
Application number
YU101385A
Other languages
English (en)
Serbo-Croatian (sh)
Other versions
YU101385A (en
Inventor
G.H. Baker
M. Beal
Original Assignee
Beecham Group Plc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10562629&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=YU45724(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Beecham Group Plc. filed Critical Beecham Group Plc.
Priority to SI8511013A priority Critical patent/SI8511013A8/sl
Publication of YU101385A publication Critical patent/YU101385A/xx
Publication of YU45724B publication Critical patent/YU45724B/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/195—Antibiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Fodder In General (AREA)
  • Electroluminescent Light Sources (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Liquid Crystal Substances (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
YU101385A 1984-06-19 1985-06-17 Postupak za dobijanje kristalnog kalcijum pseudomonata ili njegovog hidrata YU45724B (sh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SI8511013A SI8511013A8 (sl) 1984-06-19 1985-06-17 Postopek pridobivanja kristalnega kalcijevega psevdomonata ali hidrata le-tega

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848415579A GB8415579D0 (en) 1984-06-19 1984-06-19 Compounds

Publications (2)

Publication Number Publication Date
YU101385A YU101385A (en) 1988-02-29
YU45724B true YU45724B (sh) 1992-07-20

Family

ID=10562629

Family Applications (1)

Application Number Title Priority Date Filing Date
YU101385A YU45724B (sh) 1984-06-19 1985-06-17 Postupak za dobijanje kristalnog kalcijum pseudomonata ili njegovog hidrata

Country Status (27)

Country Link
US (5) US4916155A (OSRAM)
EP (1) EP0167856B1 (OSRAM)
JP (1) JPH0723373B2 (OSRAM)
KR (1) KR930002509B1 (OSRAM)
AT (1) ATE49600T1 (OSRAM)
AU (1) AU577595B2 (OSRAM)
CA (1) CA1242437A (OSRAM)
DE (1) DE3575428D1 (OSRAM)
DK (1) DK164506C (OSRAM)
ES (1) ES8604249A1 (OSRAM)
FI (2) FI84179C (OSRAM)
GB (1) GB8415579D0 (OSRAM)
GR (1) GR851470B (OSRAM)
HU (1) HU195515B (OSRAM)
IE (1) IE58118B1 (OSRAM)
IL (1) IL75536A (OSRAM)
JO (1) JO1420B1 (OSRAM)
MX (1) MX163401B (OSRAM)
MY (1) MY102549A (OSRAM)
NO (1) NO171593C (OSRAM)
NZ (1) NZ212433A (OSRAM)
PH (1) PH22951A (OSRAM)
PL (1) PL254033A1 (OSRAM)
PT (1) PT80657B (OSRAM)
YU (1) YU45724B (OSRAM)
ZA (1) ZA854549B (OSRAM)
ZM (1) ZM4185A1 (OSRAM)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8415579D0 (en) * 1984-06-19 1984-07-25 Beecham Group Plc Compounds
GB8530796D0 (en) * 1985-12-13 1986-01-22 Beecham Group Plc Pharmaceutical composition
IE59628B1 (en) * 1986-06-26 1994-03-09 Beecham Group Plc Treatment of fungal infections
US5273998A (en) * 1990-05-11 1993-12-28 Yoshitomi Pharmaceutical Industries, Ltd. Process for making an optically active 3,4-dihydro-3,4-epoxy-2H-1-benzopyran compound
GB9507825D0 (en) * 1995-04-18 1995-05-31 Wet Pieter M De Method of treatment
GB9616208D0 (en) 1996-08-01 1996-09-11 Smithkline Beecham Plc Novel Compounds
AU724070B2 (en) * 1996-10-01 2000-09-14 Smithkline Beecham Corporation Use of mupirocin for the manufacture of a medicament for the treatment of bacterial infections associated with colonisation of the nasopharynx by pathogenic organisms
CO4910145A1 (es) 1996-10-01 2000-04-24 Smithkline Beecham Corp Uso
GB9808470D0 (en) * 1998-04-22 1998-06-17 Smithkline Beecham Plc Novel process and apparatus
WO2000046389A1 (en) * 1999-02-03 2000-08-10 Biogal Gyogyszergyar Rt Process for the preparation of pseudomonic acid a antibiotic by microbiological method
CA2448547A1 (en) * 2001-06-21 2003-01-03 Biogal Gyogyszergyar Rt. Metabolic controlled fermentation process for pseudomonic acid production
WO2003065975A2 (en) 2001-12-28 2003-08-14 Biogal Gyogyszergyar Rt Processes for preparing crystalline and amorphous mupirocin calcium
IL150907A (en) * 2002-07-25 2007-07-04 Stephan Cherkez Process for the preparation of stable amorphous calcium pseudomonate
JP2007502861A (ja) * 2003-05-01 2007-02-15 レプリダイン・インコーポレーテッド 抗菌方法及び組成物
KR20060123772A (ko) * 2004-06-01 2006-12-04 테바 기오기스제르갸르 자르트쾨렌 뮈쾨되 레스즈베니타르사사그 약물의 비결정형의 제조 방법
US7619102B2 (en) * 2005-02-21 2009-11-17 Axellia Pharmaceuticals Aps Purification of mupirocin
DK1879877T3 (da) 2005-05-03 2013-04-15 Ranbaxy Lab Ltd Antimikrobielle midler
EP1752516A1 (en) * 2005-08-01 2007-02-14 The Lubrizol Corporation Dispersants
GB2441328A (en) * 2006-08-30 2008-03-05 Alpharma Aps A method for obtaining mupirocin calcium
WO2009092991A1 (en) * 2008-01-24 2009-07-30 Pliva Hrvatska D.O.O. Process for preparing crystalline calcium mupirocin dihydrate
WO2010132833A1 (en) * 2009-05-14 2010-11-18 The Regents Of The University Of Michigan Streptococcus vaccine compositions and methods of using the same
WO2012014109A1 (en) 2010-07-30 2012-02-02 Ranbaxy Laboratories Limited Heterocyclic sulfonamides as inhibitors of transfer rna synthetase for use as antibacterial agents
WO2016133471A1 (en) 2015-02-20 2016-08-25 Pharmacti̇ve İlaç Sanayi̇ Ve Ti̇caret A. Ş. A topical composition comprising mupirocin and dexpanthenol
KR102101297B1 (ko) 2019-02-15 2020-05-26 주식회사 드림테크 급속 스팀 세척기 제어방법
KR102269617B1 (ko) 2020-10-27 2021-06-24 신현호 스팀 급속제조장치 및 그 제어방법

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4071536A (en) * 1971-06-12 1978-01-31 Beecham Group Limited Antibiotics
GB1395907A (en) * 1971-06-12 1975-05-29 Beecham Group Ltd Antibiotics
GB1587058A (en) * 1976-06-15 1981-03-25 Beecham Group Ltd Oxiranylmethyltetrahydropyran derivatives
GB1577730A (en) * 1976-10-23 1980-10-29 Beecham Group Ltd Treatment of infections with pseudomonicacid salts or esters thereof
GB1577545A (en) * 1977-07-27 1980-10-22 Beecham Group Ltd Treatment of swine dysenter
CA1115699A (en) * 1978-05-20 1982-01-05 Alan D. Curzons Lithium pseudomonate and its preparation
GB2097670B (en) * 1981-03-11 1985-02-27 Beecham Group Ltd Growth promotor containing pseudomonic acid
GB8313035D0 (en) * 1983-05-12 1983-06-15 Beecham Group Plc Compound
GB8415579D0 (en) * 1984-06-19 1984-07-25 Beecham Group Plc Compounds
US4892960A (en) * 1985-01-28 1990-01-09 International Minerals & Chemical Corp. Crystalline lysocellin compositions and method of making

Also Published As

Publication number Publication date
PL254033A1 (en) 1986-04-22
CA1242437A (en) 1988-09-27
ZM4185A1 (en) 1985-11-22
ES544329A0 (es) 1986-01-16
US4916155A (en) 1990-04-10
NO171593B (no) 1992-12-28
PT80657A (en) 1985-07-01
NO171593C (no) 1993-04-07
DE3575428D1 (de) 1990-02-22
GR851470B (OSRAM) 1985-11-25
ZA854549B (en) 1986-05-28
FI88796B (fi) 1993-03-31
DK164506B (da) 1992-07-06
MY102549A (en) 1992-07-31
DK275585D0 (da) 1985-06-18
US5569672A (en) 1996-10-29
HU195515B (en) 1988-05-30
MX163401B (es) 1992-05-11
FI852407A0 (fi) 1985-06-17
HUT38654A (en) 1986-06-30
EP0167856A2 (en) 1986-01-15
EP0167856A3 (en) 1986-11-26
YU101385A (en) 1988-02-29
PH22951A (en) 1989-02-03
IL75536A0 (en) 1986-01-31
FI84179C (fi) 1991-10-25
US5191093A (en) 1993-03-02
NZ212433A (en) 1988-08-30
ATE49600T1 (de) 1990-02-15
KR930002509B1 (ko) 1993-04-03
NO852446L (no) 1985-12-20
JPS6117583A (ja) 1986-01-25
EP0167856B1 (en) 1990-01-17
DK164506C (da) 1992-11-23
JPH0723373B2 (ja) 1995-03-15
AU577595B2 (en) 1988-09-29
US5436266A (en) 1995-07-25
FI913260A0 (fi) 1991-07-04
JO1420B1 (en) 1986-11-30
FI84179B (fi) 1991-07-15
GB8415579D0 (en) 1984-07-25
DK275585A (da) 1985-12-20
IL75536A (en) 1989-01-31
IE58118B1 (en) 1993-07-14
PT80657B (en) 1987-05-04
ES8604249A1 (es) 1986-01-16
IE851506L (en) 1985-12-19
FI852407L (fi) 1985-12-20
AU4373485A (en) 1986-01-02
FI88796C (fi) 1993-07-12
KR860000291A (ko) 1986-01-27
US5792790A (en) 1998-08-11

Similar Documents

Publication Publication Date Title
YU45724B (sh) Postupak za dobijanje kristalnog kalcijum pseudomonata ili njegovog hidrata
ATE126433T1 (de) Verwendung von gamma-hydroxy-buttersäuresalzen zur herstellung von pharmazeutischen zusammensetzungen zur verwendung bei der behandlung von alkoholismus und die hergestellten zusammensetzungen.
ATE110745T1 (de) Wachstumshormonkristalle und verfahren zu deren herstellung.
DE3683266D1 (de) Antibiotikum a 40926 mannosyl aglycon.
ATE84716T1 (de) 4-chinolincarbonsaeure-derivate, brauchbar zur behandlung von haut- und muco-epithelialgewebekrankheiten.
DE58903876D1 (de) Riboflavin-4'5'-cyclo-phosphorsaeureesterchlorid, dessen herstellung und verwendung zur herstellung von riboflavin-5'-phosphat (5'-fmn) bzw. dessen natriumsalz.
DE68905657D1 (de) Verwendung von arginin-aspartat zur herstellung eines arzneimittels zur behandlung gewisser gedaechtnisstoerungen.
NO893256L (no) Fremgangsmaate for fremstilling av furyltiazolderivater.
IL51292A (en) 1,4-dioxido-2-cyanoalkylcarboxamide-3-methyl-quinoxaline derivatives,their manufacture and their use for controlling pathogenic microorganisms and for stimulating growth of animals
DE3689562D1 (de) Verfahren zur Erzeugung des menschlichen Wachstumhormons.
ATE87309T1 (de) Azol-derivate verwendbar zur kontrolle von pflanzenkrankheiten und regulierung von pflanzenwachstum.
NO901765L (no) Bensement med cellevekststimulerende middel.
IT8848237A0 (it) Procedimento per la produzione difosfati cristallini di titanio, di zirconio e misti di zirconio e titanio